Crossmark

Examining predictors of scale-up penalty in preliminary studies of health behavior interventions and subsequent larger trials: a meta-epidemiological review of diverse fields

Crossref DOI link: https://doi.org/10.1186/s40814-026-01836-4

Published Online: 2026-05-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

von Klinggraeff, Lauren https://orcid.org/0000-0002-4417-0701
Pfledderer, Christopher D.

Burkart, Sarah

Ramey, Kaitlyn

Smith, Michal

McLain, Alexander C.

Armstrong, Bridget

Weaver, R. Glenn

Okely, Anthony

Lubans, David

Ioannidis, John P. A.

Jago, Russell

Turner-McGrievy, Gabrielle

Thrasher, James

Li, Xiaoming

Beets, Michael W.
Funding

Funding for this research was provided by:

National Heart, Lung, and Blood Institute (R01HL149141)

National Heart, Lung, and Blood Institute (F31HL158016)

National Heart, Lung, and Blood Institute (F32HL154530)

National Institute of General Medical Sciences (P20GM130420)
License Information

Text and Data Mining valid from 2026-05-13

Accepted Manuscript valid from 2026-05-13
More Information

Article History

Received: 8 May 2025

Accepted: 4 May 2026

First Online: 13 May 2026

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below